She creates a custom plan that considers your lifestyle and health needs to determine which weight loss options works best for you
Ravulizumab, a C5 complement inhibitor designed on the basis of eculizumab with an extended half-life of elimination and duration of action, is an upgraded version of eculizumab with long-lasting effects, which may reduce the burden of administration (Vu et al., 2023)
This makes it a dual agonist. Instead of activating just one hormone receptor, Zepbound activates two
Results may vary.
Learn more Keep the weight off
If successful across all indications, retatrutide could receive approval for weight management , type 2 diabetes, cardiovascular risk reduction, knee osteoarthritis, and liver disease